ACTA1 and Hepatic fibrosis: As expected, Western blotting analysis also confirmed that DMN exposure would stimulate α-SMA expression, in comparison to the control, whereas a much lower level of α-SMA was observed in the SRE-treated group with respect to DMN-treated, indicating that SRE treatment could effectively eliminate hepatic fibrosis induced by DMN.